mass balance
Showing 1 - 25 of >10,000
Mass Balance Study in Healthy Subjects Trial in Suzhou ([14C]JAB-21822)
Not yet recruiting
- Mass Balance Study in Healthy Subjects
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jun 25, 2023
Mass Balance Study in Healthy Subjects Trial ([14C]HLX208)
Not yet recruiting
- Mass Balance Study in Healthy Subjects
- (no location specified)
Apr 24, 2023
Helicobacter Pylori Infection Trial in Suzhou ([14C]TNP-2198)
Completed
- Helicobacter Pylori Infection
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 15, 2023
Healthy Subjects Trial in Suzhou ([14C]JT001)
Recruiting
- Healthy Subjects
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 4, 2023
Pharmacokinetics Trial in Suzhou ([14C] ZSP1273)
Active, not recruiting
- Pharmacokinetics
- [14C] ZSP1273
-
Suzhou, ChinaThe First affiliated hospital of Suzhou university
May 15, 2023
Phase 1 Study, Healthy Volunteers Trial in Beijing ([14C]DWP14012)
Active, not recruiting
- Phase 1 Study, Healthy Volunteers
-
Beijing, ChinaBeijing GoBroad Boren Hospital
May 11, 2023
Healthy Trial in Suzhou ([14C]Iruplinalkib (WX-0593))
Completed
- Healthy
- [14C]Iruplinalkib (WX-0593)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 5, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Madison ([14C]CCX168)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
-
Madison, WisconsinCovance Clinical Research Unit, Inc.
Aug 15, 2023
Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)
Recruiting
- Imumune Thrombocytopenia(ITP) Human Mass Balance
- HMPL-523
- 150 µCi [14C]HMPL-523
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Mar 12, 2023
Breast Cancer Trial in Suzhou ([14C] TQB3616)
Not yet recruiting
- Breast Cancer
- [14C] TQB3616
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 21, 2023
Peripheral Analgesic and Anti-itch Trial in Suzhou ([14C]HSK21542)
Completed
- Peripheral Analgesic and Anti-itch
-
Suzhou, Jiangsu, Chinaf the First Affiliated Hospital of soochow University
Apr 19, 2023
Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028 Trial in Suzhou ([14C]LXI-15028)
Completed
- Healthy Subjects
- Pharmacokinetics of 14C-labeled of LXI-15028
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
May 22, 2023
Healthy Male Subjects Trial in Tokyo (TAS-303, [14C]TAS-303)
Active, not recruiting
- Healthy Male Subjects
- TAS-303, [14C]TAS-303
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Nov 17, 2022
NASH Trial in Nottingham (Aramchol)
Completed
- NASH
-
Nottingham, United KingdomQuotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nott
May 23, 2023
Primary Mild and Moderate Hypertension Trial in Suzhou (SPH3127)
Completed
- Primary Mild and Moderate Hypertension
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 6, 2022
Healthy Volunteers Trial in Groningen (DC-806, [14C]-DC-806)
Recruiting
- Healthy Volunteers
-
Groningen, NetherlandsICON Phase 1 Clinic
Sep 13, 2023
Healthy Male Subjects Trial in Tokyo ([14C] TS-142)
Completed
- Healthy Male Subjects
- [14C] TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Type II Diabetes Trial in Suzhou ([14C]HSK7653)
Completed
- Type II Diabetes
-
Suzhou, Chinathe First Affilicated Hospital of Soochow University
Dec 9, 2022
Healthy Male Subjects Trial in Tokyo (TAS-205, [14C]TAS-205)
Completed
- Healthy Male Subjects
- TAS-205, [14C]TAS-205
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022